Balili, John P.
HRN: 27-35-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2025
06/26/2025
IV
600 Mg
Q6h
Inflamed Foot With Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes